InsiderTrades

Form 4 for OLMA Olema Pharmaceuticals, Inc.

Accepted 2021-10-12 00:00:00 ET · period of report 2021-10-11 · accession 0001415889-21-004829 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2021-10-12 2021-10-11 OLMA Horn Kinney Chief BUSINESS Off S - Sale+OE $27.90 -5,251 4,936 -52% -$146.5K
D 2021-10-12 2021-10-11 OLMA Horn Kinney Chief BUSINESS Off M - OptEx $2.06 +5,251 7,041 +293% +$10.8K
D 2021-10-12 2021-10-11 OLMA Horn Kinney Chief BUSINESS Off M - OptEx $0.00 -5,251 168.0K -3% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-10-11 S D 3,146 $28.19 1,790 D — — (F3) The weighted average sale price for the transaction reported was $28.19, and the range of prices were between $27.88 and $28.62. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
2 Common Common Stock 2021-10-11 M A 5,251 $2.06 7,041 D — —
3 Common Common Stock 2021-10-11 S D 2,105 $27.47 4,936 D — — (F2) The weighted average sale price for the transaction reported was $27.47, and the range of prices were between $26.88 and $27.87. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
4 Derivative Stock Option (Right to Buy) 2021-10-11 M D 5,251 $0.00 168,042 D $2.06 · — to 2030-06-09 5,251 Common Stock (F4) The shares subject to the option vest in a series of 48 successive equal monthly installments measured from June 10, 2020, subject to the Reporting Person's continuous service through each applicable vesting date.